| Serial Number | 79294792 |
| Word Mark | OMASS |
| Filing Date | Wednesday, February 26, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 10, 2021 |
| Registration Number | 6443577 |
| Registration Date | Tuesday, August 10, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 25, 2021 |
| Goods and Services | Pharmaceutical and veterinary preparations for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; biopharmaceutical preparations for treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; chemical, biochemical and biological preparations for medical and veterinary purposes for the treatment of immune response disorders, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases, infectious diseases and cardiovascular diseases; reagents for medical use, namely reagents for in-vitro laboratory use cells for medical or clinical use, namely cells, cell lines, and cell cultures for use in the production of proteins for therapeutic use; reagents for medical use; biological reagents for medical use; therapeutic antibodies; vaccines |
| Goods and Services | Scientific and technological services, namely scientific research and development; laboratory research services in the field of chemistry, biochemistry, biotechnology, molecular sciences and mass spectrometry; medical and pharmacological research services; scientific research, namely, analysis and measurement of substances; analysis and measurement of molecules and characteristics; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research; research and development in the fields of immunology, genetic conditions, oncology, immuno-oncology, ophthalmology, haematology, neurology, respiratory diseases, metabolic conditions, infectious diseases and cardiovascular diseases; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnology research; biotechnology research, namely, biotechnology testing; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; research and development in the pharmaceutical field; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing services; drug discovery services; drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; research and development of molecules for therapeutic purposes; consultancy, advisory and/or information services in relation to all the aforesaid services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 6, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 6, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OMASS Therapeutics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | OMASS Therapeutics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | OMASS Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Saturday, October 7, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Monday, February 14, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 24, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, January 24, 2022 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 10, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 10, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Sunday, May 30, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, May 25, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 25, 2021 | PUBLISHED FOR OPPOSITION |
| Monday, May 10, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, May 5, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 5, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 20, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 15, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 14, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 14, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 29, 2021 | ASSIGNED TO EXAMINER |
| Sunday, November 22, 2020 | REFUSAL PROCESSED BY IB |
| Monday, November 2, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, November 2, 2020 | REFUSAL PROCESSED BY MPU |
| Saturday, October 10, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, October 10, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, October 9, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 6, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, October 6, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 1, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |